Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Sep-Oct;13(5C):1889-94.

The role of lipid-associated sialic acid (LSA) and prostate specific antigen (PSA) in the follow-up of prostatic cancer

U Meyer  1 , C Dierig, N Katopodis, C H De Bruijn
Affiliations
  • PMID: 7505544

The role of lipid-associated sialic acid (LSA) and prostate specific antigen (PSA) in the follow-up of prostatic cancer

U Meyer et al. Anticancer Res. 1993 Sep-Oct.

Abstract

According to the most recent US cancer statistics, prostatic cancer almost equals lung cancer as the most frequent cause of death from cancer in men. The search for diagnostic methods as well as control examinations have therefore gained great importance. The present study reveals that--in addition to rectal touch, sonography and biopsy of the prostate--the determination of both PSA as organ-specific marker and lipid-associated sialic acid (LSA) as a general tumor marker, is well suited for follow-up and monitoring treatment. With regard to the follow-up, the combined determination of PSA and LSA in serum of patients with prostatic cancer achieves a higher sensitivity as compared to PSA alone (increase of 30-40%). LSA is a good indicator for the presence of metastases. Therefore, the determination of LSA should become an integral part of treatment monitoring and detection of metastatic disease in patients with prostatic cancer.

PubMed Disclaimer